Organogenesis Holdings Inc. (FRA:2PQ)

Organogenesis Holdings Statistics

Total Valuation

FRA:2PQ has a market cap or net worth of EUR 566.95 million. The enterprise value is 660.01 million.

Market Cap	566.95M
Enterprise Value	660.01M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	126.91M
Shares Outstanding	n/a
Shares Change (YoY)	-3.51%
Shares Change (QoQ)	+3.14%
Owned by Insiders (%)	37.78%
Owned by Institutions (%)	46.22%
Float	55.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	20.80
PS Ratio	1.43
PB Ratio	1.72
P/TBV Ratio	3.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.70, with an EV/FCF ratio of -14.99.

EV / Earnings	-83.94
EV / Sales	1.65
EV / EBITDA	19.70
EV / EBIT	n/a
EV / FCF	-14.99

Financial Position

The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.11.

Current Ratio	3.32
Quick Ratio	2.57
Debt / Equity	0.11
Debt / EBITDA	1.05
Debt / FCF	-0.79
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.30% and return on invested capital (ROIC) is 0.21%.

Return on Equity (ROE)	0.30%
Return on Assets (ROA)	0.18%
Return on Invested Capital (ROIC)	0.21%
Return on Capital Employed (ROCE)	0.33%
Revenue Per Employee	456,278
Profits Per Employee	-9,048
Employee Count	869
Asset Turnover	0.97
Inventory Turnover	3.56

Taxes

Income Tax	-6.14M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.43%
50-Day Moving Average	3.99
200-Day Moving Average	3.79
Relative Strength Index (RSI)	50.22
Average Volume (20 Days)	1,163

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.12

Income Statement

In the last 12 months, FRA:2PQ had revenue of EUR 396.51 million and -7.86 million in losses. Loss per share was -0.07.

Revenue	396.51M
Gross Profit	295.38M
Operating Income	1.17M
Pretax Income	-5.29M
Net Income	-7.86M
EBITDA	16.67M
EBIT	1.17M
Loss Per Share	-0.07

Balance Sheet

The company has 54.33 million in cash and 34.78 million in debt, giving a net cash position of 19.55 million.

Cash & Cash Equivalents	54.33M
Total Debt	34.78M
Net Cash	19.55M
Net Cash Per Share	n/a
Equity (Book Value)	328.97M
Book Value Per Share	1.71
Working Capital	178.50M

Cash Flow

In the last 12 months, operating cash flow was -33.06 million and capital expenditures -10.96 million, giving a free cash flow of -44.02 million.

Operating Cash Flow	-33.06M
Capital Expenditures	-10.96M
Free Cash Flow	-44.02M
FCF Per Share	n/a

Margins

Gross margin is 74.49%, with operating and profit margins of 0.30% and 0.22%.

Gross Margin	74.49%
Operating Margin	0.30%
Pretax Margin	-1.33%
Profit Margin	0.22%
EBITDA Margin	4.20%
EBIT Margin	0.30%
FCF Margin	n/a

Dividends & Yields

FRA:2PQ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.51%
Shareholder Yield	3.51%
Earnings Yield	-1.39%
FCF Yield	-7.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:2PQ has an Altman Z-Score of 3.73 and a Piotroski F-Score of 2.

Altman Z-Score	3.73
Piotroski F-Score	2